BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20156598)

  • 1. The genetic structure of Neisseria meningitidis populations in Cuba before and after the introduction of a serogroup BC vaccine.
    Climent Y; Urwin R; Yero D; Martinez I; Martín A; Sotolongo F; Maiden MC; Pajón R
    Infect Genet Evol; 2010 May; 10(4):546-54. PubMed ID: 20156598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba.
    Climent Y; Yero D; Martinez I; Martín A; Jolley KA; Sotolongo F; Maiden MC; Urwin R; Pajón R
    J Clin Microbiol; 2010 Mar; 48(3):802-10. PubMed ID: 20042619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.
    Kristiansen PA; Diomandé F; Wei SC; Ouédraogo R; Sangaré L; Sanou I; Kandolo D; Kaboré P; Clark TA; Ouédraogo AS; Absatou KB; Ouédraogo CD; Hassan-King M; Thomas JD; Hatcher C; Djingarey M; Messonnier N; Préziosi MP; LaForce M; Caugant DA
    Clin Vaccine Immunol; 2011 Mar; 18(3):435-43. PubMed ID: 21228139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.
    Kristiansen PA; Ba AK; Sanou I; Ouédraogo AS; Ouédraogo R; Sangaré L; Diomandé F; Kandolo D; Thomas JD; Clark TA; Laforce M; Caugant DA
    BMC Infect Dis; 2013 Aug; 13():363. PubMed ID: 23914778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neisseria meningitidis disease-associated clones in Amazonas State, Brazil.
    Silva LA; Coronato B; Schlackman J; Marsh JW; Ezeonwuka C; Fernandes ACL; Souza VC; da Silva LS; de Amorim EFQ; Naveca FG; de Albuquerque BC; Amaral A; Souza ALS; Carvalho-Costa FA; Mustapha MM; Harrison LH; Barroso DE
    Infect Dis (Lond); 2018 Sep; 50(9):697-704. PubMed ID: 29623748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine.
    Bårnes GK; Kristiansen PA; Beyene D; Workalemahu B; Fissiha P; Merdekios B; Bohlin J; Préziosi MP; Aseffa A; Caugant DA
    BMC Infect Dis; 2016 Nov; 16(1):639. PubMed ID: 27814682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of PorA during a meningococcal disease epidemic.
    Devoy AF; Dyet KH; Martin DR
    J Clin Microbiol; 2005 Feb; 43(2):832-7. PubMed ID: 15695688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic.
    Dyet KH; Martin DR
    J Clin Microbiol; 2005 Feb; 43(2):838-42. PubMed ID: 15695689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited Impact of Adolescent Meningococcal ACWY Vaccination on Neisseria meningitidis Serogroup W Carriage in University Students.
    Oldfield NJ; Green LR; Parkhill J; Bayliss CD; Turner DPJ
    J Infect Dis; 2018 Jan; 217(4):608-616. PubMed ID: 29155998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.
    Caugant DA; Kristiansen PA; Wang X; Mayer LW; Taha MK; Ouédraogo R; Kandolo D; Bougoudogo F; Sow S; Bonte L
    PLoS One; 2012; 7(9):e46019. PubMed ID: 23029368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.
    Harrison LH; Shutt KA; Schmink SE; Marsh JW; Harcourt BH; Wang X; Whitney AM; Stephens DS; Cohn AA; Messonnier NE; Mayer LW
    J Infect Dis; 2010 Apr; 201(8):1208-24. PubMed ID: 20199241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBP.
    Lucidarme J; Newbold LS; Findlow J; Gilchrist S; Gray SJ; Carr AD; Hewitt J; Kaczmarski EB; Borrow R
    Clin Vaccine Immunol; 2011 Feb; 18(2):194-202. PubMed ID: 21123522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of molecular subtypes and microflora structure of Neisseria meningitidis strains isolated in Jiangxi province].
    Yang M; Zhou HJ; Yuan H; Xiong CH; Xu XQ; Chen FH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Apr; 47(4):342-6. PubMed ID: 23928641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of Neisseria meningitidis isolates recovered from 11-19-year-old meningococcal carriers in Salvador, Brazil.
    Moura ARSS; Kretz CB; Ferreira IE; Nunes AMPB; de Moraes JC; Reis MG; McBride AJA; Wang X; Campos LC
    PLoS One; 2017; 12(9):e0185038. PubMed ID: 28931058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.
    Martin DR; Ruijne N; McCallum L; O'Hallahan J; Oster P
    Clin Vaccine Immunol; 2006 Apr; 13(4):486-91. PubMed ID: 16603616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variability of Polish serogroup B meningococci (2010-2016) including the 4CMenB vaccine component genes.
    Waśko I; Gołębiewska A; Kiedrowska M; Ronkiewicz P; Wróbel-Pawelczyk I; Kuch A; Hong E; Skoczyńska A
    Vaccine; 2020 Feb; 38(8):1943-1952. PubMed ID: 31980191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.
    Tondella ML; Popovic T; Rosenstein NE; Lake DB; Carlone GM; Mayer LW; Perkins BA
    J Clin Microbiol; 2000 Sep; 38(9):3323-8. PubMed ID: 10970378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of a collection of Neisseria meningitidis isolates from Croatia, June 2009 to January 2014.
    Bukovski S; Vacca P; Anselmo A; Knezovic I; Fazio C; Neri A; Ciammaruconi A; Fortunato A; Palozzi AM; Fillo S; Lista F; Stefanelli P
    J Med Microbiol; 2016 Sep; 65(9):1013-1019. PubMed ID: 27452726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of serogroup C Neisseria meningitidis isolated in China.
    Zhang X; Shao Z; Yang E; Xu L; Xu X; Li M; Ren J; Zhu Y; Yang F; Liang X; Mayer LW; Xu J; Jin Q
    J Med Microbiol; 2007 Sep; 56(Pt 9):1224-1229. PubMed ID: 17761487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population structure of invasive Neisseria meningitidis in the United States, 2011-15.
    Potts CC; Joseph SJ; Chang HY; Chen A; Vuong J; Hu F; Jenkins LT; Schmink S; Blain A; MacNeil JR; Harrison LH; Wang X
    J Infect; 2018 Nov; 77(5):427-434. PubMed ID: 29964139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.